The DRD2 TaqIA polymorphism and demand of dopaminergic medication in Parkinson's disease.
about
PharmGKB summary: dopamine receptor D2Krüppel-like factor 11 differentially couples to histone acetyltransferase and histone methyltransferase chromatin remodeling pathways to transcriptionally regulate dopamine D2 receptor in neuronal cells.Pharmacogenetics of Parkinson's disease - through mechanisms of drug actions.Pharmacokinetic evaluation of pramipexole.Pharmacological treatment and the prospect of pharmacogenetics in Parkinson's disease.Pharmacogenomics in neurology: current state and future steps.Parkinson's disease pharmacogenomics: new findings and perspectives.Pharmacogenetics of drug response in Parkinson's disease.Pharmacogenetic considerations in the treatment of Parkinson's disease.How close are we to individualized medicine for Parkinson's disease?Novel insights in pharmacogenetics of drug response in Parkinson's disease.Polymorphisms in the dopamine transporter gene are associated with visual hallucinations and levodopa equivalent dose in Brazilians with Parkinson's disease.Genetics and Treatment Response in Parkinson's Disease: An Update on Pharmacogenetic Studies.Large differences in levodopa dose requirement in Parkinson's disease: men use higher doses than women.
P2860
Q34970259-5BDF3E97-35D1-42A1-9298-7A3F7E22BC04Q35921695-66140A34-DD92-4EF5-A8B4-D73103942AB0Q37583417-A4F82FFB-2C99-4E56-9A4B-79A6EB79CD7BQ37926588-24091F22-DAC3-4298-B2E9-1F0C5C34297AQ37957393-FFE1290F-4A46-48CE-948E-4F0FB06D3CF3Q37967607-84F4234F-5177-4F88-9DD4-4FC88B4CE467Q38241678-7CD2DC84-1CC1-46D7-A385-C041BBFF83C7Q38250117-93045CF4-443A-44EB-A3AE-1DB9040F0A22Q38364825-BBEC559D-2A2A-414C-8FB5-50F104488E87Q38814888-1C6FEE57-644E-43FB-88CD-982E5BE45D98Q43171707-4DB00322-9930-4AE3-91D2-4B312AC186DDQ44687266-996398D6-B024-4185-A4CC-3944B20610F5Q47648607-51595910-BA5E-4C94-B039-58FB3B208894Q51792730-46A3445D-0E84-4430-AE8D-A5D8E75BC6E8
P2860
The DRD2 TaqIA polymorphism and demand of dopaminergic medication in Parkinson's disease.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
The DRD2 TaqIA polymorphism and demand of dopaminergic medication in Parkinson's disease.
@en
type
label
The DRD2 TaqIA polymorphism and demand of dopaminergic medication in Parkinson's disease.
@en
prefLabel
The DRD2 TaqIA polymorphism and demand of dopaminergic medication in Parkinson's disease.
@en
P2093
P2860
P50
P356
P1433
P1476
The DRD2 TaqIA polymorphism and demand of dopaminergic medication in Parkinson's disease.
@en
P2093
Anne Grünewald
Bernd Janetzky
Jens C Möller
Michael Knapp
Sebastian Paus
P2860
P304
P356
10.1002/MDS.21901
P407
P577
2008-03-01T00:00:00Z